These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10382906)

  • 1. Adult glycogenosis II with paracrystalline mitochondrial inclusions and Hirano bodies in skeletal muscle.
    Fernández R; Fernández JM; Cervera C; Teijeira S; Teijeiro A; Domínguez C; Navarro C
    Neuromuscul Disord; 1999 May; 9(3):136-43. PubMed ID: 10382906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult glycogenosis type II (Pompe's disease): morphological abnormalities in muscle and skin biopsies compared with acid alpha-glucosidase activity.
    Wierzba-Bobrowicz T; Lewandowska E; Lugowska A; Rola R; Stepień T; Ryglewicz D; Pasennik E
    Folia Neuropathol; 2007; 45(4):179-86. PubMed ID: 18176891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Reducing body"-like inclusions in skeletal muscle in childhood-onset acid maltase deficiency.
    Jay V; Christodoulou J; Mercer-Connolly A; McInnes RR
    Acta Neuropathol; 1992; 85(1):111-5. PubMed ID: 1337420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed or late-onset type II glycogenosis with globular inclusions.
    Sharma MC; Schultze C; von Moers A; Stoltenburg-Didinger G; Shin YS; Podskarbi T; Isenhardt K; Tews DS; Goebel HH
    Acta Neuropathol; 2005 Aug; 110(2):151-7. PubMed ID: 15986226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset glycogen storage disease type II with reducing body-like inclusions.
    Gayathri N; Yasha TC; Vani S; Taly AB; Nalini A; Shankar SK
    Clin Neuropathol; 2010; 29(1):36-40. PubMed ID: 20040332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe course of glycogen storage disease type II (Pompe's disease) without development of cardiomegalia.
    Ullrich K; Gröbe H; Korinthenberg R; von Bassewitz DB
    Pathol Res Pract; 1986 Oct; 181(5):627-32. PubMed ID: 2947052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathology of type II skeletal muscle glycogenosis. A light and electron-microscopic study.
    Hudgson P; Fulthorpe JJ
    J Pathol; 1975 Jul; 116(3):139-47. PubMed ID: 172619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of skeletal muscle cells in adult-onset glycogenosis type II (Pompe disease): ultrastructural study.
    Lewandowska E; Wierzba-Bobrowicz T; Rola R; Modzelewska J; Stepień T; Lugowska A; Pasennik E; Ryglewicz D
    Folia Neuropathol; 2008; 46(2):123-33. PubMed ID: 18587706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of heterozygotes for glycogenosis 2 (acid maltase deficiency).
    Loonen MC; Schram AW; Koster JF; Niermeijer MF; Busch HF; Martin JJ; Brouwer-Kelder B; Mekes W; Slee RG; Tager JM
    Clin Genet; 1981 Jan; 19(1):55-63. PubMed ID: 7006871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid maltase deficiency (type II glycogenosis). Morphological and biochemical study of a childhood phenotype.
    Martin JJ; De Barsy T; De Schrijver ; Leroy JG; Palladini G
    J Neurol Sci; 1976 Nov; 30(1):155-66. PubMed ID: 1068222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pseudodystrophic muscle glycogenosis in adults. (Acid maltase deficiency syndrome) (author's transl)].
    Gullotta F; Stefan H; Mattern H
    J Neurol; 1976; 213(3):199-216. PubMed ID: 61260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile acid maltase deficiency. II. Muscle fiber hypertrophy and the ultrastructure of end-stage fibers.
    Griffin JL
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 45(1):37-50. PubMed ID: 6199886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma cell inclusions in Pompe's disease (glycogenosis type II). Second case of a new anomaly].
    Pralle H; Löffler H
    Blut; 1976 Nov; 33(5):332. PubMed ID: 186140
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy.
    Winkel LP; Kamphoven JH; van den Hout HJ; Severijnen LA; van Doorn PA; Reuser AJ; van der Ploeg AT
    Muscle Nerve; 2003 Jun; 27(6):743-51. PubMed ID: 12766987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiomuscular lysosomal glycogenosis in adults without known enzyme deficiency. A cause of familial myocardiopathy and lysosomal glycogen overload with normal acid maltase].
    Bru P; Pellissier JF; Gatau-Pelanchon J; Faugère G; de Barsy T; Levy S; Gérard R
    Arch Mal Coeur Vaiss; 1988 Jan; 81(1):109-14. PubMed ID: 3130016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural observations on the retina in type II glycogenosis (Pompe's disease).
    Goebel HH; Kohlschütter A; Pilz H
    Ophthalmologica; 1978; 176(2):61-8. PubMed ID: 273184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncommon case of type II glycogenosis.
    de Barsy T; Ferrière G; Fernandez-Alvarez E
    Acta Neuropathol; 1979 Aug; 47(3):245-7. PubMed ID: 384741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine glycogenosis type II. Biochemical and morphological characteristics of skeletal muscle in culture.
    Di Marco PN; Howell JM; Dorling PR
    Neuropathol Appl Neurobiol; 1984; 10(5):379-95. PubMed ID: 6395034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pompe's disease: ultrastructural alterations of muscle tissue in parents.
    Pellegrini G; Mosca G; Cerri C
    Acta Neurol Scand; 1978 Mar; 57(3):216-22. PubMed ID: 276244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells.
    van der Ploeg AT; Bolhuis PA; Wolterman RA; Visser JW; Loonen MC; Busch HF; Reuser AJ
    J Neurol; 1988 Sep; 235(7):392-6. PubMed ID: 3065462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.